Literature DB >> 23584094

10-million-years AGO: argonaute on chromatin in yeast and human, a conserved mode of action?

Annick Harel-Bellan1, Maya Ameyar Zazoua, Christophe Rachez, Christian Muchardt, Eric Batsché.   

Abstract

Whereas in yeast the function and mode of action of nuclear RNAi are well documented, mammalian nuclear RNAi is a matter of debates. Several papers support a role for nuclear Argonaute in alternative splicing. However, the molecular mechanism remains elusive. Here, we discuss the human nuclear RNAi mechanism in light of what is known of the yeast process.

Entities:  

Keywords:  AGO; AS lincRNA; mammals; nuclear RNAi; splicing

Mesh:

Substances:

Year:  2013        PMID: 23584094      PMCID: PMC4042589          DOI: 10.4161/trns.24582

Source DB:  PubMed          Journal:  Transcription        ISSN: 2154-1272


  23 in total

Review 1.  Post-transcriptional gene silencing across kingdoms.

Authors:  C Cogoni; G Macino
Journal:  Curr Opin Genet Dev       Date:  2000-12       Impact factor: 5.578

Review 2.  Dicing and slicing: the core machinery of the RNA interference pathway.

Authors:  Scott M Hammond
Journal:  FEBS Lett       Date:  2005-09-27       Impact factor: 4.124

3.  Antisense transcription in the mammalian transcriptome.

Authors:  S Katayama; Y Tomaru; T Kasukawa; K Waki; M Nakanishi; M Nakamura; H Nishida; C C Yap; M Suzuki; J Kawai; H Suzuki; P Carninci; Y Hayashizaki; C Wells; M Frith; T Ravasi; K C Pang; J Hallinan; J Mattick; D A Hume; L Lipovich; S Batalov; P G Engström; Y Mizuno; M A Faghihi; A Sandelin; A M Chalk; S Mottagui-Tabar; Z Liang; B Lenhard; C Wahlestedt
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

Review 4.  The Argonautes.

Authors:  L Joshua-Tor
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2006

Review 5.  Targets of RNA-directed DNA methylation.

Authors:  Marjori Matzke; Tatsuo Kanno; Bruno Huettel; Lucia Daxinger; Antonius J M Matzke
Journal:  Curr Opin Plant Biol       Date:  2007-08-16       Impact factor: 7.834

6.  Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells.

Authors:  Daniel H Kim; Louisa M Villeneuve; Kevin V Morris; John J Rossi
Journal:  Nat Struct Mol Biol       Date:  2006-08-27       Impact factor: 15.369

Review 7.  RNA interference and heterochromatin in the fission yeast Schizosaccharomyces pombe.

Authors:  Robert A Martienssen; Mikel Zaratiegui; Derek B Goto
Journal:  Trends Genet       Date:  2005-08       Impact factor: 11.639

8.  Natural antisense as potential regulator of alternative initiation, splicing and termination.

Authors:  Espen Enerly; Zeng Sheng; Kuo-Bin Li
Journal:  In Silico Biol       Date:  2005

9.  Transcriptional silencing of a transgene by RNAi in the soma of C. elegans.

Authors:  Alla Grishok; Jina L Sinskey; Phillip A Sharp
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

10.  RNA polymerase II acts as an RNA-dependent RNA polymerase to extend and destabilize a non-coding RNA.

Authors:  Stacey D Wagner; Petro Yakovchuk; Benjamin Gilman; Steven L Ponicsan; Linda F Drullinger; Jennifer F Kugel; James A Goodrich
Journal:  EMBO J       Date:  2013-02-08       Impact factor: 11.598

View more
  3 in total

1.  RNAi factors are present and active in human cell nuclei.

Authors:  Keith T Gagnon; Liande Li; Yongjun Chu; Bethany A Janowski; David R Corey
Journal:  Cell Rep       Date:  2014-01-02       Impact factor: 9.423

2.  The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery.

Authors:  Hanxue Sun; Sanyukta Rana; Zhe Wang; Kun Zhao; Martina Schnölzer; Jan Provaznik; Thilo Hackert; Qingjie Lv; Margot Zöller
Journal:  J Oncol       Date:  2019-08-07       Impact factor: 4.375

Review 3.  Argonaute Proteins: From Structure to Function in Development and Pathological Cell Fate Determination.

Authors:  Madlen Müller; Francesco Fazi; Constance Ciaudo
Journal:  Front Cell Dev Biol       Date:  2020-01-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.